Experimental study on anti-tumor effect of splenocytes induced by anti-CD3 McAb, PHA and IL-2

Abstract

The proliferation of splenocytes from healthy adults was induced by anti-CD3 McAb, PHA and IL-2. The proliferative capability and anti-tumor activity as well as phenotypes of the splenocytes cultured in different medium systems were studied. The results showed that anti-CD3 McAb and PHA not only enhanced the proliferation of splenocytes induced by IL-2, but also produced synergism if used simultaneously. The expressions of CD4 and Tac of cellular surface markers were increased after splenocytes were induced by anti-CD3 McAb and PHA. The results of anti-tumor activity of LAK cells suggested that PHA had the capability to promote anti-tumor activity of LAK cells by both direct and indirect pathways, but anti-CD3 McAb indirectly promoted anti-tumor activity of LAK cells by enhancing splenocyte proliferation.

Keywords

Anti-CD3 McAb / PHA / IL-2 / LAK cells

References

[1] GrimmE A, MazumderA, ZhangH Z, et al.. Lymphokine-activated killer cells phenomenon. J Exp Med, 1982, 155: 1823-1823

[2] RosenbergS A, MuleJ J, SpiessP J, et al.. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high dose rIL-2. J Exp Med, 1985, 161: 1169-1169

[3] SchwarzR E, HiserodtJ C. The importance of splenectomy for the adoptive immunotherapy of cancer. Med Hypotheses, 1989, 28: 165-165

[4] GarbrechtF C, RussoC, WekslerM E. Long-term growth of human T cell lines and cloness on anti-CD3 antibody-treated tissue culture plates. J Immunol Methods, 1988, 107: 137-137

[5] LondeiM, Grubeck-LoebensteinB, De BerardingsP, et al.. Efficient propagation and cloning of human T cells in the absence of antigen by means of OKT3, interleukn-2 and antigen-presenting cells. Scand J Immunol, 1988, 27: 35-35

[6] 1988; 4(4): 217

[7] 1992; 12 (3): 139

[8] 1991; 11(1): 35

[9] SchwinzepR, FranklinR A, DomenicoJ, et al.. Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells. J Immunol, 1992, 148: 1322-1322

[10] 1990; 6(1): 22

[11] EichmannK, JonssonJ I, FalkI, et al.. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentration of the cell antigen receptor with enther Lyt-2 or L3T4. Eur J Immunol, 1987, 17: 643-643